Brimapitide

N/A

Report date: 2024/08/08 17:09:57
NME

Base Information

Drug NameBrimapitide
Drug Alias NameXG102 peptideAM111 peptideAM-111D-JNKI-1XG-102
ClassificationSmall molecules > Synthetic peptide
Mechanisms of Actionc-Jun N-terminal kinase 1 inhibitors
Targetsc-Jun N-terminal kinase 1
Therapy Area/IndicationsPainInflammationCataract +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXigen Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAuris MedicalAuris Medical IncXigen Sa +[4] 
Active IndicationsN/A
Inactive IndicationsPainInflammationCataract +[4] 

Other Information

ATC CodeN/A
Related LinksN/A